1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  6. News
  7. Summary
    002603   CNE1000015S0

SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

(002603)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-06-23
24.96 CNY   -1.69%
05/27Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021
CI
05/02Yiling Pharmaceutical's Q1 Profit Tumbles 28% as Sales Plummet
MT
04/29Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Dividend for the Year 2020

05/11/2021 | 03:42pm EDT

Shijiazhuang Yiling Pharmaceutical Co., Ltd. at its annual general meeting held on May 10, 2021, approved cash dividend of CNY 10.00000000 per 10 shares (tax included) for the year 2020.


© S&P Capital IQ 2021
All news about SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
05/27Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021
CI
05/02Yiling Pharmaceutical's Q1 Profit Tumbles 28% as Sales Plummet
MT
04/29Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year ..
CI
04/28Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua..
CI
04/18Yiling Pharma's Shares Sink on Doubts Over COVID-19 Drug Efficacy
MT
2021Shunten International Limited Enters into Cooperation Framework Agreement with Shijiazh..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced a financing transaction
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
2021HS Bio Sdn. Bhd. Enters into MOU with Shijiazhuang Yiling Pharmaceutical Co., Ltd
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces 2020 Final Distribution Plan to ..
CI
More news
Financials
Sales 2022 12 094 M 1 808 M 1 808 M
Net income 2022 1 642 M 245 M 245 M
Net Debt 2022 - - -
P/E ratio 2022 25,5x
Yield 2022 -
Capitalization 41 701 M 6 234 M 6 234 M
Capi. / Sales 2022 3,45x
Capi. / Sales 2023 2,92x
Nbr of Employees 15 155
Free-Float 41,3%
Chart SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Duration : Period :
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 24,96 CNY
Average target price 31,49 CNY
Spread / Average Target 26,2%
EPS Revisions
Managers and Directors
Xiang Jun Wu Director & General Manager-Marketing Center
Chen Guang Li Chief Financial Officer & Director
Yi Ling Wu Chairman
Xue Dong Gao Chairman-Supervisory Board
Zhen Wang Independent Director